The Parker Institute for Cancer Immunotherapy fully supports the Senate’s agreement of a $2 billion increase in funding for the National Institutes of Health. In our recent opinion piece in STAT News, we called for a renewed commitment to federal funding for biomedical research. This increase demonstrates that advancing scientific research and discovery is a top priority for our nation’s leaders. We applaud the Senate for taking this step, and we recognize that we must all play a role if we want continue to be a world leader in innovation. It is critical that all sectors from the biomedical ecosystem — industry, government, academia and philanthropy sponsored research and development — invest in research to get profound breakthrough treatments to more patients faster.
You Might Also Like...
Point of View
“The NIH is in danger of losing its edge in creating biomedical innovations” OpEd published in STAT News
January 3, 2018
The NIH is in danger of losing its edge in creating biomedical innovations
STAT News | January 3, 2018